About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6276000
Allelic
Composition
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
Genetic
Background
C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu
Cell Lines HEPD0651_8_C07
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Abhd6tm1a(EUCOMM)Hmgu mutation (0 available); any Abhd6 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• islets show elevated monoacylglycerol production in response to glucose
• islet extracts show an approximate 50% reduced monoacylglycerol hydrolytic activity that is insensitive to inhibition by WWL70 unlike wild-type islets
• females on a chow diet show reduced insulin secretion during oral glucose tolerance test (OGTT)
• islets show an increase in glucose-stimulated insulin secretion at 8.3 and 16.7 mM glucose (J:215257)
• islets show elevated KCl-stimulated insulin secretion (J:215257)
• 6 week old males on a chow diet show no differences in glucose tolerance during oral glucose tolerance test despite increased insulin secretion (J:234876)

adipose tissue
• visceral fat weight is reduced by about 40% in females, with no change in males, when fed a high fat diet
• fat mass is markedly decreased in females and modestly decreased in males fed a high fat diet
• mice fed a high fat diet show smaller adipocytes with fewer lipid deposits in the brown adipose tissue
• mice fed a high fat diet show smaller adipocytes in the visceral and inguinal adipose tissue
• marker analysis indicates induction of browning-related genes in visceral and subcutaneous adipose tissue of high fat diet fed mice
• visceral fat from high fat diet fed mice shows enhanced glucose uptake under basal and insulin-stimulated conditions, with effects more pronounced in females than males

homeostasis/metabolism
• brown adipose tissue from high fat fed mice shows a nearly 2-fold increase in beta-oxidation
• males treated with the PPARalpha antagonist GW6471 show normalized beta-oxidation levels in brown adipose tissue
• females on a chow diet show reduced insulin secretion during oral glucose tolerance test (OGTT)
• islets show an increase in glucose-stimulated insulin secretion at 8.3 and 16.7 mM glucose (J:215257)
• islets show elevated KCl-stimulated insulin secretion (J:215257)
• 6 week old males on a chow diet show no differences in glucose tolerance during oral glucose tolerance test despite increased insulin secretion (J:234876)
• mice fed a 60% high fat diet show much lower insulinemia during OGTT than controls
• plasma insulin during oral glucose tolerance test increases indicating elevated insulinemia with unchanged glycemia upon glucose load
• however, mice exhibit unaltered glucose tolerance and insulin sensitivity
• mice maintain their body temperature in cold better than controls during cold-induced thermogenesis for 3 hours
• energy expenditure as a function of metabolic mass is higher in both the dark and light phases, during the last 24 hour period, and at both room temperature and 30 degrees Celsius in mice fed a high fat diet
• males treated with the PPARalpha antagonist GW6471 show reduced energy expenditure at 30 degrees
• mice show less body weight gain during high fat diet feeding
• the decrease in body weight gain is greater in females (about 30% at week 8) than in males (about 12% at week 8)
• body weight gain is still lower after pair feeding for 2 weeks
• males treated with the PPARalpha antagonist GW6471 show slightly elevated body weight gain without altering food intake
• mice fed a high fat diet exhibit elevated volume of oxygen during light and dark phases and during the last 24 hour period at both room temperature and 30 degrees Celsius, indicating elevated respiration
• however, respiratory exchange ratio is not affected
• males treated with the PPARalpha antagonist GW6471 show lowered oxygen consumption
• mice fed a 60% high fat diet for 8 weeks show improved glucose tolerance during oral glucose tolerance test (OGTT)
• females on a chow diet show better glucose tolerance than wild-type mice, however males show normal glucose metabolism on regular chow
• glucose tolerance remains improved after pair feeding
• glucose infusion rate (index of insulin sensitivity) in high-fat diet fed mice is higher
• mice fed a 60% high fat diet show enhanced insulin sensitivity during insulin tolerance test
• females on a chow diet show slightly reduced body weight gain over 3-24 weeks of age and cumulative food intake over 5-16 weeks of age and show better glucose tolerance than wild-type mice but with reduced insulin secretion during OGTT, indicating that females are more insulin sensitive
• proteins related to insulin resistance such as ICAM-1, IGFBP-1, and resistin are decreased in the plasma
• insulin sensitivity remains increased after pair feeding
• males treated with the PPARalpha antagonist GW6471 show lowered insulin sensitivity
• islets exhibit elevated total and 1-monoacylglycerol content and a moderate increase in 2-monoacylglycerol at high glucose
• high glucose induces a higher increase in 1-palmitoylglycerol and 1-stearoylglycerol in islets
• maximal changes in islets are seen in saturated-fatty acid-containing monoacylglycerol species
• liver triglyceride content is decreased in mice fed a high fat diet
• total 1-MAG hydrolase activity is decreased in visceral and brown adipose tissues of high fat diet fed mice

behavior/neurological
• mice show reduced cumulative food intake during high fat diet feeding showing an approximate 7% reduction at weeks 6-8 of the diet
• females on a chow diet show slightly reduced cumulative food intake over 5-16 weeks of age
• food intake is unaltered in males treated with the PPARalpha antagonist GW6471
• mice fed a high fat diet show increased locomotor activity over a 24 hour time period and during the dark phase, with a greater increase in females than males
• however, mice do not exhibit changes in anxiety or depressive behavior in the elevated-plus maze, the open-field, and forced swim test
• males treated with the PPARalpha antagonist GW6471 show reduced locomotor activity

cellular
• visceral fat from high fat diet fed mice shows enhanced glucose uptake under basal and insulin-stimulated conditions, with effects more pronounced in females than males
• soleus muscle from high fat diet fed mice shows enhanced glucose uptake under basal and insulin-stimulated conditions, with effects more pronounced in females than males
• brown adipose tissue from high fat fed mice shows a nearly 2-fold increase in beta-oxidation
• males treated with the PPARalpha antagonist GW6471 show normalized beta-oxidation levels in brown adipose tissue

growth/size/body
• fat mass is markedly decreased in females and modestly decreased in males fed a high fat diet
• females on a chow diet show slightly reduced body weight gain over 3-24 weeks of age
• mice show less body weight gain during high fat diet feeding
• the decrease in body weight gain is greater in females (about 30% at week 8) than in males (about 12% at week 8)
• body weight gain is still lower after pair feeding for 2 weeks
• males treated with the PPARalpha antagonist GW6471 show slightly elevated body weight gain without altering food intake

liver/biliary system
• mice fed a high fat diet show a decrease in fat content in the liver
• liver triglyceride content is decreased in mice fed a high fat diet
• mice fed a high fat diet show a reduction in liver weight

muscle
• soleus muscle from high fat diet fed mice shows enhanced glucose uptake under basal and insulin-stimulated conditions, with effects more pronounced in females than males


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory